Akanda (AKAN) Total Current Liabilities (2020 - 2025)
Akanda (AKAN) posted quarterly Total Current Liabilities of $6.2 million for Q4 2025, up 70.43% year-over-year from $3.6 million in Q4 2024, and up 118.06% quarter-over-quarter from $2.8 million in Q2 2025.
Akanda (AKAN) Total Current Liabilities (2020 - 2025) Analysis & Trends
Akanda's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $6.2 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 70.43% year-over-year to $6.2 million; the TTM figure through Dec 2025 stood at $6.2 million (up 70.43% YoY), while the FY2025 annual figure was $6.2 million, up 70.43% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $6.2 million, up from $2.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $12.4 million in Q2 2023, with the low at $2.8 million in Q2 2025.
- The 5-year median for Total Current Liabilities is $6.3 million (2022), against an average of $7.2 million.
- The sharpest annual moves came in 2021 and 2024: Total Current Liabilities soared 202.71% in 2021, then plunged 64.24% in 2024.
- Akanda's Total Current Liabilities stood at $8.3 million in 2021, then advanced by 13.05% to $9.3 million in 2022, then climbed by 8.81% to $10.2 million in 2023, then slumped by 64.24% to $3.6 million in 2024, then soared by 70.43% to $6.2 million in 2025.
- Business Quant data shows AKAN's Total Current Liabilities at $6.2 million in Q4 2025, $2.8 million in Q2 2025, and $3.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Akanda | 266,801.66 | 266,801.66 | - | 6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.20 Mn |
| Jun 30, 2025 | 2.84 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Jun 30, 2022 | 6.27 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Dec 31, 2020 | 2.73 Mn |